Evidence map›Paper›PMID 28087666›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing.

Jason A Vander Heiden, Panos Stathopoulos, Julian Q Zhou, Luan Chen, Tamara J Gilbert, Christopher R Bolen, Richard J Barohn, Mazen M Dimachkie, Emma Ciafaloni, Teresa J Broering and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. An updated AL-base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. B cell tolerance and autoimmunity: Lessons from repertoires.The Journal of experimental medicine · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Jason A Vander HeidenInterdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511.ORCID 0000-0002-1474-310X
Panos StathopoulosDepartment of Neurology, Yale School of Medicine, New Haven, CT 06511.
Julian Q ZhouInterdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511.ORCID 0000-0001-9602-2092
Luan ChenInterdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511.
Tamara J GilbertAbVitro, Inc., Boston, MA 02210.
Christopher R BolenDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305.
Richard J BarohnDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS 66160.ORCID 0000-0002-0383-6845
Mazen M DimachkieDepartment of Neurology, University of Kansas Medical Center, Kansas City, KS 66160.ORCID 0000-0002-7148-989X
Emma CiafaloniDepartment of Neurology, University of Rochester School of Medicine, Rochester, NY 14642.
Teresa J BroeringAbVitro, Inc., Boston, MA 02210.
Francois VigneaultAbVitro, Inc., Boston, MA 02210.ORCID 0000-0001-5634-5794
Richard J NowakDepartment of Neurology, Yale School of Medicine, New Haven, CT 06511.
Steven H KleinsteinInterdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511; kevin.oconnor@yale.edu steven.kleinstein@yale.edu.
Kevin C O'ConnorDepartment of Neurology, Yale School of Medicine, New Haven, CT 06511; kevin.oconnor@yale.edu steven.kleinstein@yale.edu.ORCID 0000-0002-7056-419X
Yale University · USUniversity of Kansas Medical Center · USStanford University · USUniversity of Rochester · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
MEDICAL INFORMATICS RESEARCH TRAINING AT YALET15LM007056 · NLM · YALE UNIVERSITY · PI Mark Bender Gerstein, LUCILA OHNO-MACHADO · 1987 to 2026
$22.2M
Mechanisms of autoimmunity in myasthenia gravisR01AI114780 · NIAID · YALE UNIVERSITY · PI Kevin C O'Connor · 2016 to 2026
$4.7M
COMPUTATIONAL TOOLS FOR THE ANALYSIS OF HIGH-THROUGHPUT IMMUNOGLOBULIN SEQUENCING EXPERIMENTSR01AI104739 · NIAID · YALE UNIVERSITY · PI KLEINSTEIN, STEVEN H. · 2014 to 2022
$3.6M
YALE BIOMEDICAL SUPERCOMPUTER: NEUROSCIENCES10RR019895 · NCRR · YALE UNIVERSITY · PI WILLIAMS, KENNETH ROBERT · 2004 to 2004
$1.6M
High Performance Computing Instrumentation for Yale University Biomedical HPC CenS10RR029676 · NCRR · YALE UNIVERSITY · PI BJORNSON, ROBERT DEAN · 2011 to 2011
$588k
NCATS NIH HHS UL1 TR001863NCRR NIH HHS S10 RR019895NCRR NIH HHS S10 RR029676NIAID NIH HHS R01 AI104739NIAID NIH HHS R01 AI114780NLM NIH HHS T15 LM007056
6 · The paper itself

Abstract

Myasthenia gravis (MG) is a prototypical B cell-mediated autoimmune disease affecting 20-50 people per 100,000. The majority of patients fall into two clinically distinguishable types based on whether they produce autoantibodies targeting the acetylcholine receptor (AChR-MG) or muscle specific kinase (MuSK-MG). The autoantibodies are pathogenic, but whether their generation is associated with broader defects in the B cell repertoire is unknown. To address this question, we performed deep sequencing of the BCR repertoire of AChR-MG, MuSK-MG, and healthy subjects to generate ∼518,000 unique V

Indexed as

AdolescentAdultAutoantibodiesB-LymphocytesFemaleHigh-Throughput Nucleotide SequencingHumansImmune ToleranceImmunologic MemoryMaleMiddle AgedMyasthenia GravisProtein KinasesReceptor Protein-Tyrosine KinasesReceptors, Antigen, B-CellReceptors, Cholinergicacetylcholine receptor kinaseAutoantibodiesMUSK protein, humanProtein KinasesReceptor Protein-Tyrosine KinasesReceptors, Antigen, B-CellReceptors, Cholinergic

Identifiers

PMID28087666
PMCPMC5296243
OpenAlexW2577359160

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.